Thiamine deficiency in a patient with recurrent renal cell carcinoma who developed weight loss with normal appetite and loss of energy soon after nivolumab treatment.
Hideki OnishiTakashi OkabeNozomu UchidaSuguru ShirotakeMaki TodoMasafumi OyamaMayumi IshidaPublished in: Palliative & supportive care (2021)
In patients treated with nivolumab, it is necessary to pay careful attention to TD when proceeding with the treatment. It is hoped that future research may reveal the link between nivolumab administration and TD.